MAPP BIOPHARMACEUTICAL, INC.

Address

6160 LUSK BLVD STE 105
SAN DIEGO, CA, 92121-2740

http://www.mappbio.com

Information

DUNS: 137551797
# of Employees: 40

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Direct sequencing of serum antibodies after infection

    Amount: $255,046.00

    Project Summary Monoclonal antibodies mAbs are a well validated drug platform with exquisite specificity diversity and potency They offer the lowest risk class of drug for development through lice ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  2. Rapid Response Agents Against Filovirus Outbreaks Using Vectored Immunoprophylaxis

    Amount: $240,221.00

    Summarty Abstract Vectored immunoprophylaxis or antibody gene transfer for infectious disease is a promising new strategy to provide protection against high risk infectious agents supplementing v ...

    SBIRPhase I2016Department of Health and Human Services
  3. Ricin Toxin Protective Monoclonal Antibodies with Improved Serum Half-Life

    Amount: $999,927.75

    Ricin is a category B toxin due to its ease of acquisition, dissemination, and the high potential for morbidity and mortality after exposure. Ricin in semi-purified or purified form is extremely toxic ...

    SBIRPhase II2016Department of Defense Army
  4. Pseudomonas antibodies with designed glycans

    Amount: $228,758.00

    DESCRIPTION provided by applicant Pseudomonas aeruginosa PA an opportunistic Gram negative bacterium is one of the leading nosocomial pathogens worldwide PA is responsible for localized infec ...

    SBIRPhase I2015Department of Health and Human Services
  5. Novel Immunotherapy for Brain Cancer

    Amount: $224,988.00

    DESCRIPTION (provided by applicant): Glioblastoma is the most common primary brain tumor in adults. While many patients achieve disease remission following treatment with surgical resection, radiatio ...

    SBIRPhase I2014Department of Health and Human Services
  6. A human monoclonal for RSV prophylaxis

    Amount: $600,000.00

    DESCRIPTION provided by applicant Respiratory syncytial virus RSV is the leading cause of lower respiratory tract illness in infants and young children worldwide In premature neonates RSV infec ...

    SBIRPhase I2014Department of Health and Human Services
  7. An Immunoprotectant for Marburg Virus

    Amount: $2,999,994.00

    DESCRIPTION provided by applicant Mortality rates associated with Marburg virus MARV outbreaks range from to over MARV is included by the Centers for Disease Control and Prevention as am ...

    SBIRPhase II2014Department of Health and Human Services
  8. An SEB Immunoprotectant

    Amount: $2,306,794.00

    DESCRIPTION provided by applicant Staphylococcal enterotoxin B SEB Category B agent a toxin that commonly causes classic food poisoning and can cause a non menstrual toxic shock syndrome TSS ...

    SBIRPhase II2014Department of Health and Human Services
  9. Ricin Toxin Protective Monoclonal Antibodies with Improved Serum Half-Life

    Amount: $149,876.77

    Ricin is a category B toxin due to its ease of acquisition, dissemination, and the high potential for morbidity and mortality after exposure. There are currently no methods of preventing or treating r ...

    SBIRPhase I2014Department of Defense Army
  10. A Monoclonal Cocktail for CDI

    Amount: $299,986.00

    DESCRIPTION (provided by applicant): Clostridium difficile associated disease (CDI) is an important cause of morbidity in hospital and nursing home patients, and is being increasingly recognized as an ...

    SBIRPhase I2012Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government